Loading...
Loading...
Browse all stories on DeepNewz
VisitOutcome of Hubei Aoks Bio-Tech legal proceedings by November 2025?
Guilty on all charges • 25%
Guilty on some charges • 25%
Not guilty • 25%
Case dismissed • 25%
U.S. federal court records and announcements
DOJ Indicts Hubei Aoks Bio-Tech for Exporting Fentanyl Precursors and Xylazine
Nov 9, 2024, 07:05 PM
The U.S. Department of Justice has charged Hubei Aoks Bio-Tech Co. Ltd., a Wuhan-based chemical company, with exporting illegal fentanyl precursors and adulterants. The company, along with its director and three senior employees, faces a 13-count federal grand jury indictment. The charges include conspiracy to manufacture and distribute fentanyl and the introduction of misbranded drugs into interstate commerce. The indictment alleges that from November 2016 to November 2023, the company sold significant amounts of fentanyl precursors to customers in the United States. Additionally, the company is accused of manufacturing and distributing xylazine, a drug known for its flesh-eating effects, often referred to as a 'zombie drug'.
View original story
Convicted • 25%
Acquitted • 25%
Plea Bargain • 25%
Case Dismissed • 25%
No charges filed • 25%
Fines imposed • 25%
Executives prosecuted • 25%
Other • 25%
Conviction • 25%
Acquittal • 25%
Plea Bargain • 25%
Case Dismissed • 25%
Convicted • 25%
Acquitted • 25%
Charges dropped • 25%
Awaiting trial • 25%
Hesai wins • 25%
Hesai loses • 25%
Settlement reached • 25%
Case dismissed • 25%
Guilty of all charges • 25%
Guilty of some charges • 25%
Not guilty • 25%
Case dismissed • 25%
Yes • 50%
No • 50%
Cassava Sciences wins the lawsuits • 25%
Cassava Sciences settles the lawsuits • 25%
Cassava Sciences loses the lawsuits • 25%
Lawsuits are dismissed • 25%
Favorable ruling for Cassava Sciences • 25%
Unfavorable ruling for Cassava Sciences • 25%
Settlement • 25%
Case dismissed • 25%
Cleared of charges • 25%
Charged but not convicted • 25%
Convicted • 25%
Ongoing investigation • 25%
Firm found guilty • 25%
Firm found not guilty • 25%
Settlement reached • 25%
Case dismissed • 25%
European Union • 25%
Other • 25%
China • 25%
United States • 25%